Synthesis, biological activity and docking study of some new isatin Schiff base derivatives

Medicinal Chemistry Research

Volumn 21, Issue 11, 2012, Pages 3730-3740

  Azizian, Javad ^a   Mohammadi, Mohammad K ^b   Firuzi, Omidreza ^c   Razzaghi Asl, Nima ^d   Miri, Ramin ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytotoxicity; Docking; Isatin; Schiff base; Synthesis

Indexed keywords

(DIHYDROTHIAZOL 2 YLIMINO)INDOLIN 2 ONE; 3 (1H BENZO[D]IMIDAZOL 2 YLIMINO)INDOLIN 2 ONE; 3 (4 CHLOROTHIAZOL 2 YLIMINO)INDOLIN 2 ONE; 3 (4 METHYLISOXAZOL 3 YLIMINO)INDOLIN 2 ONE; 3 (5 CHLOROPYRIDIN 2 YLIMINO)INDOLIN 2 ONE; 3 (5 METHYLISOXAZOL 2(5H)YLIMINO)INDOLIN 2 ONE; 3 (5 METHYLISOXAZOL 3 YLIMINO)INDOLIN 2 ONE; 3 (6 CHLORO 2 METHYLPYRIMIDIN 4 YLIMINO)INDOLIN 2 ONE; 3 (BENZO[D]THIAZOL 2 YLIMINO)INDOLIN 2 ONE; ANTINEOPLASTIC AGENT; CISPLATIN; ISATIN DERIVATIVE; SCHIFF BASE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MOLECULAR DOCKING;

EID: 84871456424     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9896-6     Document Type: Article

References (41)

1. Abad-Zapatero C, Metz JT (2005) Ligand efficiency indices as guideposts for drug discovery. Drug Discov Today 10(7):464-469
2. Andrews PR, Craik DJ, Martin JL (1984) Functional group contributions to drug-receptor interactions. J Med Chem 27(12): 1648-1657
3. Azizian J, Soozangarzadeh S, Jadidi K (2001) Microwave-induced one-pot synthesis of some new spiro [3H-indole-3,500(400 H)-[1,2,4]-triazoline]-2-ones. Synth Commun 31(7):1069-1073
4. Azizian J, Morady AV, Soozangarzadeh S, Asadi A (2002) Synthesis of novel spiro-[3H-indole-3,30-[1,2,4] triazolidine]-2-ones via azomethine imines. Tetrahedron Lett 43(52):9721-9723
5. Cosconati S, Forli S, Perryman AL, Harris R, Goodsell DS, Olson AJ (2010) Virtual screening with AutoDock: Theory and practice. Expert Opin Drug Discov 5(6):597-607
6. d'Ischia M, Palumbo A, Prota G (1988) Adrenalin oxidation revisited. New products beyond the adrenochrome stage. Tetrahedron 44(20):6441-6446
7. Erickson JA, Jalaie M, Robertson DH, Lewis RA, Vieth M (2004) Lessons in molecular recognition: The effects of ligand and protein flexibility on molecular docking accuracy. J Med Chem 47(1):45-55
8. Glover V, Halket JM, Watkins PJ, Clow A, Goodwin BL, Sandier M (1988) Isatin: identity with the purified endogenous monoamine oxidase inhibitor tribulin. J Neurochem 51(2):656-659
9. Hasegawa M, Nishigaki N, Washio Y, Kano K, Harris PA, Sato H, Mori I, West RI, Shibahara M, Toyoda H (2007) Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors. J Med Chem 50(18):4453-4470
10. Hevener KE, Zhao W, Ball DM, Babaoglu K, Qi J, White SW, Lee RE (2009) Validation of molecular docking programs for virtual screening against dihydropteroate synthase. J Chem Inf Model 49(2):444-460
11. Holmes K, Roberts OL, Thomas AM, Cross MJ (2007) Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 19(10):2003-2012
12. Hopkins AL, Groom CR, Alex A (2004) Ligand efficiency: A useful metric for lead selection. Drug Discov Today 9(10):430-431
13. Hossain MM, Islam N, Khan R, Islam M (2008) Cytotoxicity study of dimethylisatin and its heterocyclic derivatives. Bangladesh J Pharmacol 2(2):66-70
14. Iyer RA, Hanna PE (1995) N-(carbobenzyloxy) isatin: A slow binding [alpha]-keto lactam inhibitor of [alpha]-chymotrypsin. Bioorganic Med Chem Lett 5(1):89-92
15. Logan JC, Fox MP, Morgan JH, Makohon AM, Pfau CJ (1975) Arenavirus inactivation on contact with N-substituted isatin beta-thiosemicarbazones and certain cations. J Gen Virol 28(3):271
16. Matesic L, Locke JM, Bremner JB, Pyne SG, Skropeta D, Ranson M, Vine KL (2008) N-phenethyl and N-naphthylmethyl isatins and analogues as in vitro cytotoxic agents. Bioorganic Med Chem 16(6):3118-3124
17. Miri R, Motamedi R, Rezaei MR, Firuzi O, Javidnia A, Shafiee A (2011) Design, synthesis and evaluation of cytotoxicity of novel chromeno [4, 3-b] quinoline derivatives. Archiv der Pharmazie (Epub ahead of print)
18. Morris GM, Huey R, Olson AJ (2008) Using AutoDock for ligandreceptor docking. Curr Protoc Bioinformatics 11(3):34-37
19. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30(16):2785-2791
20. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65(1-2):55-63
21. Pandeya SN, Sriram D, Nath G, De Clercq E (1999a) Synthesis antibacterial, antifungal and anti HIV activity of Schiff's and Mannich bases of isatin with N-[6-chlorobenz thiazole-2-yl]thiosemicarbazide. Indian J Pharm Sci 61:358-361
22. Pandeya SN, Sriram D, Nath G, De Clercq E (1999b) Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-Amino-2-methylmercapto quinazolin-4(3H)-one. Pharm Acta Helv 74(1):11-17
23. Pandeya SN, Yogeeswari P, Sriram D, De Clercq E, Pannecouque C, Witvrouw M (1999c) Synthesis and screening for anti-HIV activity of some N-Mannich bases of isatin derivatives. Chemotherapy 45(3):192-196
24. Pandeya SN, Sriram D, Nath G, De Clercq E (2000) Synthesis, antibacterial, antifungal and anti-HIV activities of norfloxacin Mannich bases. Eur J Med Chem 35(2):249-255
25. Pervez H, Ramzan M, Yaqub M, Mohammed Khan K (2011) Synthesis, cytotoxic and phytotoxic effects of some new N4-Aryl substituted isatin-3- thiosemicarbazones. Lett Drug Des Discov 8(5):452-458
26. Phosrithong N, Ungwitayatorn J (2010) Molecular docking study on anticancer activity of plant-derived natural products. Med Chem Res 19:817-835
27. Sarangapani MR, Reddy VM (1994) Pharmacological evaluation of 1-(N,N-disubstituted aminomethyl)-3-imino-(2-phenyl-3,4-dihydro-4-oxo- quinazolin-3-yl) indolin-2-ones. Indian J Pharm Sci 56:174-177
28. Sellers RP, Alexander LD, Johnson VA, Lin CC, Savage J, Corral R, Moss J, Slugocki TS, Singh EK, Davis MR (2010) Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives. Bioorganic Med Chem 18(18):6822-6856
29. Shuttleworth SJ, Nasturica D, Gervais C, Siddiqui MA, Rando RF, Lee N (2000) Parallel synthesis of isatin-based serine protease inhibitors. Bioorganic Med Chem Lett 10(22):2501-2504
30. Silva JFM, Garden SJ, Pinto AC (2001) The chemistry of isatins: A review from 1975 to 1999. J Brazilian Chem Soc 12(3):273-324
31. Singh SP, Shukla SK, Awasthi LP (1983) Synthesis of some 3-(40-nitrobenzoylhydrazone)-2-indolinones as potential antiviral agents. Curr Sci 52(16):766-769
32. Sousa SF, Fernandes PA, Ramos MJ (2006) Protein-ligand docking: current status and future challenges. Proteins 65:15-26
33. Sridhar SK, Saravanan M, Ramesh A (2001) Synthesis and antibacterial screening of hydrazones, Schiff and Mannich bases of isatin derivatives. Eur J Med Chem 36(7-8):615-625
34. Strawn LM, McMahon G, App H, Schreck R, Kuchler WR, Longhi MP, Hui TH, Tang C, Levitzki A, Gazit A (1996) Flk-1 as a target for tumor growth inhibition. Cancer Res 56(15):3540
35. Sun L, Tran N, Liang C, Tang F, Rice A, Schreck R, Waltz K, Shawver LK, McMahon G, Tang C (1999) Design, synthesis, and evaluations of substituted 3-[(3-or 4-carboxyethylpyrrol-2-yl) methylidenyl] indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. J Med Chem 42(25): 5120-5130
36. Varma RS, Khan IA (1977) Potential biologically active agents. X. Synthesis of 3-Arylimino-2-indolinones, and their 1-methyland 1-morpholino/piperidinomethyl derivatives as excystment and cysticidal agents against Schizopyrenus russelli. Polish J Pharmacol Pharm 29(5):549
37. Varma RS, Nobles WL (1967) Synthesis and antiviral and antibacterial activity of certain N-dialkylaminomethylisatin betathiosemicarbazones. J Med Chem 10:972-974
38. Varma RS, Nobles WL (1975) Antiviral, antibacterial, and antifungal activities of isatin N Mannich bases. J Pharm Sci 64(5):881-882
39. Vine KL, Locke JM, Ranson M, Pyne SG, Bremner JB (2007) In vitro cytotoxicity evaluation of some substituted isatin derivatives. Bioorganic Med Chem 15(2):931-938
40. Vyas V, Jain A, Gupta A (2008) Virtual screening: A fast tool for drug design. Sci Pharm 76:333-360
41. Webber SE, Tikhe J, Worland ST, Fuhrman SA, Hendrickson TF, Matthews DA, Love RA, Patick AK, Meador JW, Ferre RA (1996) Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease. J Med Chem 39(26): 5072-5082